Two COVID-19 Outpatient Antibody Drugs Show Encouraging Results

Regeneron’s cocktail appeared to reduce viral load and the need for further medical care. Eli Lilly’s experimental treatment resulted in reduced viral load and hospitalizations.

Read the full article here

Related Articles